Skip to main content
Premium Trial:

Request an Annual Quote

Ignyta, Leiden U Medical Center Evaluate Epigenetic Signatures for Synovitis, RA

NEW YORK (GenomeWeb News) – Autoimmune molecular diagnostics firm Ignyta today said it is working with Leiden University Medical Center to evaluate epigenetic signatures of patients with early synovitis and rheumatoid arthritis.

Financial and other terms of the collaboration were not disclosed.

"With the signing of this collaboration with LUMC, Ignyta now has a global reach to study patients with undifferentiated arthritis and rheumatoid arthritis, taking us another step closer to achieving our goal of developing a diagnostic assay for patients with early RA," Jonathan Lim, co-founder, chairman, and CEO of Ignyta, said in a statement.

Based in San Diego, Ignyta was founded in 2011 with technology licensed from the University of California, San Diego. The company was formerly called NexDx. Last month, it announced it raised $5.5 million in an expanded Series B financing round.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.